氧化三甲胺在老年常见脑血管疾病中的研究进展

doi:10.3969/j.issn.1003-9198.2022.01.003

[1] 王陇德. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
[2] 《中国脑卒中防治报告2018》编写组. 我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J]. 中国循环杂志, 2019, 34(2): 105-119.
[3] PHAM Q D, WOLDE-KIDAN A, GUPTA A, et al.Effects of urea and TMAO on lipid self-assembly under osmotic stress conditions[J]. J Phys Chem B, 2018, 122(25): 6471-6482.
[4] HEIANZA Y, MA W, MANSON J E, et al.Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies[J]. J Am Heart Assoc, 2017, 6(7): e004947.
[5] YIN J, LIAO S X, HE Y, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack[J]. J Am Heart Assoc, 2015, 4(11):e002699.
[6] ZHOU Z, LU J, LIU W, et al. Advances in stroke pharmacology[J]. Pharmacol Ther, 2018, 191:23-42.
[7] YANG T, SANTISTEBAN M M, RODRIGUEZ V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6): 1331-1340.
[8] LIA L, ZHU S, HU Z H, et al. The distribution and epidemic characteristics of cerebrovascular disease in followed-up hypertension patients[J]. Sci Rep, 2021, 11(1):9366.
[9] MIAO J, LING A V, MANTHENA P V, et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis[J]. Nat Commun, 2015, 6: 6498.
[10] CHEN M L, ZHU X, RAN L, et al. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway[J]. J Am Heart Assoc, 2017, 6(9):e006347.
[11] GE X, ZHENG L, ZHUANG R, et al. The gut microbial metabolite trimethylamine N-oxide and hypertension risk: a systematic review and dose-response Meta-analysis[J]. Adv Nutr, 2020, 11(1): 66-76.
[12] NIE J, XIE L, ZHAO B, et al. Serum trimethylamine N-oxide concentration is positively associated with first stroke in hypertensive patients[J]. Stroke, 2018, 49(9): 2021-2028.
[13] UFNAL M, JAZWIEC R, DADLEZ M, et al. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin Ⅱ in rats[J]. Can J Cardiol, 2014, 30(12): 1700-1705.
[14] BANERJEE C, CHIMOWITZ M I.Stroke caused by atherosclerosis of the major intracranial arteries[J]. Circ Res, 2017, 120(3):502-513.
[15] SELDIN M M, MENG Y, QI H, et al.Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB[J]. J Am Heart Assoc, 2016, 5(2): e002767.
[16] MA G H, BING P, CHEN Y, et al. Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion[J]. Biosci Rep, 2017, 37(2): BSR20160244.
[17] STANCU C S, SANDA G M, DELEANU M, et al.Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters[J]. Mol Nutr Food Res, 2014, 58(3): 559-568.
[18] TANG W H W, WANG Z, FAN Y, et al.Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure:refining the gut hypothesis[J]. J Am Coll Cardiol, 2014, 64(18): 1908-1914.
[19] BURCHFIEL C M, CURB J D, RODRIGUEZ B L, et al. Glucose intolerance and 22-year stroke incidence: The Honolulu Heart Program[J]. Stroke, 1994, 25(5): 951-957.
[20] ORMSTAD H, AASS H, AMTHOR K F, et al. Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue[J]. Int J Neurosci, 2012, 122(11): 682-690.
[21] HEIANZA Y, SUN D, XIANG L, et al. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS LOST trial[J]. Gut, 2018, 68(2):263-270.
[22] SHAN Z, SUN T, HUANG H,et al. Association between microbiota-dependent metabolite trimethylamine-N -oxide and type 2 diabetes[J]. Am J Clin Nutr, 2017, 106(3):888-894.
[23] 侯典宾, 梅雨, 吴洪亮, 等. 脑供血动脉闭塞的研究进展[J]. 中国实用神经疾病杂志, 2019, 22(2): 228-232.
[24] ROHRMANN S, LINSEISEN J, ALLENSPACH M, et al. Plasma concentrations of trimethylamine-N-oxide are directly associated with dairy food consumption and low-grade inflammation in a German adult population[J]. J Nutr, 2016, 146(2): 283-289.
[25] LI D, KE Y, ZHAN R, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment inmice[J]. Aging Cell, 2018, 17(4): e12768.
[26] TATZELT J, PRUSINER S B, WELCH W J. Chemical chaperones interfere with the formation of scrapie prion protein[J]. Embo J, 1996, 15(23): 6363-6373.
[27] ALMA J, ANCHALA K, ADITI S, et al. Conformational ensembles of α-synuclein derived peptide with different osmolytes from temperature replica exchange sampling[J]. Frontiers Neurosci, 2017, 11: 684.
[28] CHO C E, TAESUWAN S, MALYSHEVA O V, et al.Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial[J]. Mol Nutr Food Res, 2017, 61(1): 1600324.
[29] LEBLHUBER F, STEINER K, SCHUETZ B, et al. Probiotic supplementation in patients with Alzheimer′s dementia-an explorative intervention study[J]. Curr Alzheimer Res, 2018, 15(12): 1106-1113.
[30] TENORE G C, CARUSO D, BUONOMO G, et al. Lactofermented annurca apple puree as a functional food indicated for the control of plasma lipid and oxidative amine levels: results from a randomised clinical trial[J]. Nutrients, 2019, 11(1): 122.
[31] EPSTEIN S E, SPEIR E, ZHOU Y F, et al. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus[J]. Lancet, 1996, 348 (suppl 1): s13.
[32] TANG W, WANG Z, LEVISON B S, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J]. New Eng J Med, 2013, 368(17): 1575-1584.
[33] KOETH R A, WANG Z, LEVISON B S, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nature Med, 2013, 19(5): 576-585.
[34] LEAL-WITT M J, LLOBET M, SAMINO S, et al. Lifestyle intervention decreases urine trimethylamine N-oxide levels in prepubertal children with obesity[J]. Obesity, 2018, 26(10): 1603-1610.
[35] WANG Z, ROBERTS A B, BUFFA J A, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell, 2015, 163(7): 1585-1595.
[36] RYAN P M, LONDON L E, BJORNDAHL T C, et al. Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E^-/-mice[J]. Microbiome, 2017, 5(1): 1-13.
[37] SHIH D M, ZHU W, SCHUGAR R C, et al. Genetic deficiency of Flavin-containing monooxygenase 3 (Fmo3) protects against thrombosis but has only a minor effect on plasma lipid levels-brief report[J]. Arterioscler Thromb Vasc Biol, 2019, 39(6): 1045-1054.
[38] CLAESSON M J, JEFFERY I B, CONDE S, et al. Gut microbiota composition correlates with diet and health in the elderly[J]. Nature, 2012, 488(7410): 178-184.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	XU Jinyan, XIA Congcong, YANG Hongmei. Establishment and validation of a Nomogram to predict the risk of pulmonary infection in elderly patients with stroke [J]. Practical Geriatrics, 2024, 38(5): 452-437.
[2]	ZHANG Lili, LI Jing, DING Linfeng, SUN Jingxian, CAI Jingbo. Predictive value of carotid atherosclerosis plaque for ischemic stroke events in patients with nonvalvular atrial fibrillation [J]. Practical Geriatrics, 2024, 38(3): 236-239.
[3]	DING Zhiqing, YANG Xiang, YAN Yuhan, LIU Beibei, LIU Zhenzhen, XIE Caizhong. Effect of Thera-Band elastic band on lower limb motor function in the patients with post-stroke hemiplegia [J]. Practical Geriatrics, 2024, 38(2): 162-165.
[4]	. [J]. Practical Geriatrics, 2023, 37(11): 1153-1155.
[5]	NIU Cui, YANG Hua, ZHANG Xiao-xia, LI Zhi-wen, YIN Hai-qing. Influencing factors of hemorrhagic transformation in elderly patients with acute cerebral infarction after thrombolysis with alteplase [J]. Practical Geriatrics, 2023, 37(10): 1035-1038.
[6]	CHEN Li-rong, YE Xiao-li. Correlation between sarcopenia and post-stroke swallowing dysfunction in elderly patients with stroke [J]. Practical Geriatrics, 2023, 37(9): 947-950.
[7]	YANG Dan-dan, JIANG Lin-zhi, LI Li-yan, GENG De-qin, LI Lei. Value of systemic immune inflammation index in predicting hemorrhage transformation after thrombolysis in elderly patients with stroke [J]. Practical Geriatrics, 2023, 37(8): 789-793.
[8]	YAO He-ling, WANG Yu, WANG Xin, FENG Li-na, YANG Yue-qing, ZHAO Tong-tong, HAN De-chang, MA Meng-hua. Analysis of influencing factors of deep medullary vein visual score and its correlation with total burden of cerebral small vessel disease [J]. Practical Geriatrics, 2023, 37(8): 811-814.
[9]	YANG Wen-jie, LI Yan-li, ZHOU Yan-jun, LI Lan, MU Bin, WANG Jie. Clinical characteristics of stroke combined with sarcopenia and the effect of early microecological enteral nutrition intervention [J]. Practical Geriatrics, 2023, 37(8): 823-827.
[10]	YU Dong-qing, CHE-Lu. Effect and prognosis of dual anti-platelet therapy based on cilostazol in elderly patients with acute cerebral infarction combined with clopidogrel resistance [J]. Practical Geriatrics, 2023, 37(8): 843-847.
[11]	. [J]. Practical Geriatrics, 2023, 37(8): 858-860.
[12]	. [J]. Practical Geriatrics, 2023, 37(7): 728-731.
[13]	. [J]. Practical Geriatrics, 2023, 37(7): 737-740.
[14]	ZHUANG Xin, ZHANG Chao, XU Hua, MENG Qing-yu, WU Li-li, DING Yu-qing, ZHANG Qian, ZHANG Li-xia. Effect of environmental stimulation intervention on lower limbs motor function in elderly patients with post-stroke hemiplegia [J]. Practical Geriatrics, 2023, 37(6): 569-572.
[15]	BAI Jian-bing, WANG Yang, LI Zi-biao, XIANG Wen-jie. Effect of Solumbra technology in the treatment of elderly patients with cerebral infarction and the change of nerve injury markers [J]. Practical Geriatrics, 2023, 37(6): 603-606.